पित्तवाहिनी कर्करोग (Bile duct cancer)
A two-arm randomized phase III, open-label prospective non-inferiority study ofirinotecan versus oxaliplatin or 5-FU based chemotherapy mFOLFOX or CAPOX forpatients with locally advanced/ metastatic biliary tract cancers BTC previouslytreated with gemcitabine-cisplatin based chemotherapy.
हॉस्पिटलशी संपर्क साधा
रजिस्ट्रीमध्ये या हॉस्पिटलला ट्रायलचा मुख्य संपर्क म्हणून दिलं आहे. कोणते हॉस्पिटल्स रुग्ण घेत आहेत, हे त्यांना विचारा.
रजिस्ट्री सारांश (तांत्रिक)
A two-arm randomized phase III, open-label prospective non-inferiority study of irinotecan versus oxaliplatin / 5-FU based chemotherapy (mFOLFOX/CAPOX) for patients with locally advanced/ metastatic biliary tract cancers (BTC) previously treated with gemcitabine-cisplatin based chemotherapy. - (BTC-SELECT)
Sponsor: टाटा मेमोरियल हॉस्पिटल
CTRI, इंडियाच्या trial registry वर CTRI/2022/01/039568
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, 12 Oct 2026 चा data
Last updated on the registry 1 Jun 2026 · read by us 5 Nov 2026